US Stock Reports, Quotes and News
TCS leaders discuss integrating with top academic institutions, AI evolution, margin improvement, productivity focus, back to office transition, campus hiring, diversified portfolio growth, and expectations for FY25. Samir Seksaria says: \”The pricing is stable, so it is a more disciplined execution and focus on operational rigour which has delivered this margin.\”
Amit Sachdeva from HSBC Securities discusses market strategies, positive outlook on Indian market, manufacturing growth, and sectoral preferences. Despite challenges, anticipates market growth with a focus on robust sectors and balanced investments for long-term returns. Sachdeva says: \”The structural momentum for India is here to stay and that is the reason we maintain a little bit of positive bias on India, which remains an overweight market for us .\”
Sabharwal advises caution in volatile markets, suggesting opportunities in capex stocks like NCC and Ahluwalia Contracts. He highlights the importance of minimal debt and strategic stock selection for long-term investment success. In IT, downside is limited, but valuations are not cheap and that is why the upside also is restricted. So, it is a no-go sector in Sabharwal\’s view.
Aditya Arora provides insights on stock recommendations, including ONGC and Thermax. He also advises on Senco Gold\’s strong performance, the bullish outlook on the metals pack, trading opportunities in Vodafone, and key levels for Nifty and Bank Nifty. Arora says: \”The metal index is trading at 9002 odd levels. I still think it is a buy; the upside which I see is 9500 to 9600.\”
Swaminathan Aiyar critiques the BJP manifesto for lacking major structural reforms in critical areas like education and employment. Modi\’s focus on continuity and scaling up existing programmes is highlighted, with no significant tax cuts expected. Aiyar sayse the BJP is so confident that it does not think it has to compete in freebies. This is a very positive thing from the point of view of investors.
Sanjiv Bhasin says I \”there is a lot of froth on the markets including the domestic market.\” He discusses market trends, advising caution and specific investments. He further highlights the impact of China on metals, Zomato\’s market performance, as well as InterGlobe\’s dominance despite competitor challenges, recommending strategic investment approaches.
Ajay Srivastava of Dimensions Corporate says \”we are in that zone where people are comfortable where they are and therefore willing to carry the investment and also make more investment. So, yes, there are fundamental factors, but to me the most important is human psychology. We are feeling good today and when we feel good, we want to do things and become more expensive.\”
Foram Parekh shares insights on CDMO companies\’ positive outlook post-Covid correction, potential impact of Biosecure Law, concerns about Laurus\’s earnings improvement, Sun Pharma\’s specialty sales focus, and recommendations for pharma sector growth with Lupin and Dr Reddy\’s.
Sudeep Shah, from SBI Securities, predicts market consolidation and bullish movement towards 22,950-23,000. He further Recommends Aditya Birla Capital and MCX stocks and anticipates positive trends in the pharma sector, specifically mentioning Concord Bio.
Market expert Joshi praises TCS\’s outstanding financial performance, expecting a stock re-rating. Anticipates positive sector impact and growth in BFSI, energy, manufacturing, life sciences, and healthcare industries based on TCS\’s stellar results.
Mirae Asset Investment Managers are bullish on India\’s economy, emphasizing growth prospects. Ankit Jain sees opportunities in midcap companies, consumer, and financial services sectors. Positive outlook despite stretched valuations, with focus on earnings growth and investment opportunities in various sectors. Jain says: \”The 1-year forward P/E ratio for Nifty stands at 22.5x, while for the Midcap 100, it is 24.5x, representing a premium of 12-15% over their respective 10-year averages.\”
Deven Choksey emphasizes individual stock investments over market view, focusing on sectors like IT, specialty chemicals, and pharma. He remains cautious on market exuberance and suggests strategic investments during corrections for long-term gains. Choksey says: \”The market is scaling up too quickly and too early, maybe that is where one is not fully comfortable.\”